From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research

被引：0

作者：

Cynthia L. Hsu

Rohit Loomba

机构：

[1] University of California at San Diego,Division of Gastroenterology and Hepatology, Department of Medicine

[2] VA San Diego Healthcare System,Department of Medicine

[3] University of California at San Diego,MASLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine

[4] University of California at San Diego,The Herbert Wertheim School of Public Health and Human Longevity Science

来源：

Nature Metabolism | 2024年 / 6卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Non-alcoholic liver disease (NAFLD) is now metabolic dysfunction-associated steatotic liver disease (MASLD), emphasizing the key metabolic factors of obesity, insulin resistance, vascular dysfunction and dyslipidaemia. Here, we discuss impacts on the existing body of clinical and preclinical liver disease research and on research moving forward.

引用

页码：600 / 602

页数：2

共 50 条

[21] Evolving liver disease insights from NAFLD to MASLD
Fan, Xiude
Song, Yongfeng
Zhao, Jiajun
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2024, 35 (08): : 683 - 686
[22] From NAFLD to MASLD: Meta-analysis and systematic review of NAFLD patients in Turkiye in terms of metabolic profile and MASLD potential
Akdas, Sevginur
Yazihan, Nuray
HEPATOLOGY FORUM, 2024, 5 (03): : 126 - 138
[23] From NAFLD to MASLD: When metabolic comorbidity matters
Hong, Shan
Sun, Lei
Hao, Yiwei
Li, Ping
Zhou, Yuling
Liang, Xiuxia
Hu, Julong
Wei, Hongshan
ANNALS OF HEPATOLOGY, 2024, 29 (02)
[24] Is the change from NAFLD to MASLD driven by political correctness?
Sanal, Madhusudana Girija
JOURNAL OF HEPATOLOGY, 2024, 80 (02) : e74 - e76
[25] New antipsychotics: Preclinical and clinical research
Gerlach, J
Casey, DE
PSYCHOPHARMACOLOGY, 1996, 124 (1-2) : 1 - 1
[26] Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort
Sanchez-Torres, Cristian
Tovar, Ana Ramirez
Chatman, Kelsey
Morris, Heather L.
Yu, Feng
Mospan, Andrea R.
Diehl, Anna Mae
Leung, Daniel H.
Viswanathan, Preeti
Squires, James E.
Palle, Sirish
Vos, Miriam B.
HEPATOLOGY COMMUNICATIONS, 2024, 8 (11)
[27] CHANGE IN NOMENCLATURE AND DEFINITION FROM NAFLD TO MASLD MAINTAINS THE DISEASE SEVERITY DETERMINING ASSOCIATION BETWEEN TYPE 2 DM AND MASLD - THE RESULTS OF MULTI-CENTRE INDIAN CONSORTIUM ON MASLD (ICOM-D)
Duseja, Ajay
Choudhary, Narendra
De, Arka
Mehta, Manu
Singh, Shivaram
Anirvan, Prajna
Shalimar
Mukewar, Shrikant
Mukewar, Saurabh
Kar, Sanjib
Goyal, Omesh
Venkataraman, Jayanthi
Devadas, Krishnadas
Dixit, V. K.
Mehta, Varun
Maiwall, Rakhi
Ranjan, Piyush
Nagral, Aabha
Arora, Anil
Praharaj, Dibyalochan
Sharma, Brij
Valsan, Arun Koottumakkal
Dadhich, Sunil
Nijhawan, Sandeep
Roy, Akash
Padaki, Nagaraja Rao
Shukla, Akash
Asati, Pankaj
Gupta, Rohit
Saigal, Sanjiv
Narayanasamy, K.
Mehta, Rajiv
Bhattacharyya, Mallika
Prasad, V. G.
Koshy, Abraham
Alam, Seema
Sanyal, Arun
HEPATOLOGY, 2024, 80 : S886 - S887
[28] Comparison of NAFLD, MAFLD, and MASLD Prevalence and Clinical Characteristics in Asia Adults
Huang, Xinjuan
Yu, Ruoling
Tan, Xinyun
Guo, Manjie
Xia, Yuanqin
Zou, Huihui
Liu, Xuelian
Qin, Chunxiang
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (01)
[29] Prognosis of MAFLD vs. NAFLD and implications for a nomenclature change
Wong, Vincent Wai-Sun
Lazarus, Jeffrey, V
JOURNAL OF HEPATOLOGY, 2021, 75 (06) : 1267 - 1270
[30] From NAFLD to MAFLD to MASLD: Looking for the Best Pediatric Label
Iorio, Raffaele
Di Dato, Fabiola
Spagnuolo, Maria Immacolata
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (05): : 575 - 576

← 1 2 3 4 5 →